Journal Club E19: BLING III: Continuous vs Intermittent Beta-Lactam Infusion in ICU Sepsis

from AZense Journal Club · host Azense Medical Education

Does infusing piperacillin-tazobactam or meropenem as a continuous drip improve 90-day survival compared to standard intermittent dosing in ICU sepsis?

Episode metadata supplied by the publisher feed · Published Aug 11, 2025

Embed this episode

Attribution link and audio player

Ready to play

Journal Club E19: BLING III: Continuous vs Intermittent Beta-Lactam Infusion in ICU Sepsis

0:00 6:14

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of AZense Journal Club?

This episode is 6 minutes long.

When was this AZense Journal Club episode published?

This episode was published on August 11, 2025.

Can I download this AZense Journal Club episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!